These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21466711)

  • 61. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.
    Tonegutti M; Girardi V
    Radiol Med; 2008 Feb; 113(1):65-75. PubMed ID: 18338128
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development.
    Gibreel WO; Boughey JC
    Ann Surg Oncol; 2016 Nov; 23(12):3838-3842. PubMed ID: 27364498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinicopathological features of the mucocele-like lesions in the breast].
    Ding HY; Yang GZ
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):31-4. PubMed ID: 18509982
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
    Sneige N; Staerkel GA
    Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunohistochemical staining for cyclin D1 and Ki-67 aids in the stratification of atypical ductal hyperplasia diagnosed on breast core biopsy.
    Hameed O; Ghali VS; Tartter PI; Mizrachi H
    Am J Clin Pathol; 2005 Dec; 124(6):862-72. PubMed ID: 16416735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
    Irfan K; Brem RF
    Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision.
    Chan PMY; Chotai N; Lai ES; Sin PY; Chen J; Lu SQ; Goh MH; Chong BK; Ho BCS; Tan EY
    Breast; 2018 Feb; 37():13-17. PubMed ID: 29040892
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 72. US-guided 14G core needle biopsy: comparison between underestimated and correctly diagnosed breast cancers.
    Kim H; Youk JH; Kim JA; Gweon HM; Jung WH; Son EJ
    Asian Pac J Cancer Prev; 2014; 15(7):3179-83. PubMed ID: 24815467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
    Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
    J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is there an Upgrading to Malignancy at Surgery of Mucocele-Like Lesions Diagnosed on Percutaneous Breast Biopsy?
    Diorio C; Provencher L; Morin J; Desbiens C; Poirier B; Poirier É; Hogue JC; Jacob S; Côté G
    Breast J; 2016; 22(2):173-9. PubMed ID: 26662058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surgical excision outcome after radial scar without atypical proliferative lesion on breast core needle biopsy: a single institutional analysis.
    Hou Y; Hooda S; Li Z
    Ann Diagn Pathol; 2016 Apr; 21():35-8. PubMed ID: 27040928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mucocele-like tumor of the breast caused by ductal carcinoma in situ: a case report.
    Kato M; Oda K; Kubota T; Kato M; Akiyama F; Nimura Y
    Breast Cancer; 2003; 10(2):157-62. PubMed ID: 12736570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mucin extravasation in breast core biopsies--clinical significance and outcome correlation.
    Begum SM; Jara-Lazaro AR; Thike AA; Tse GM; Wong JS; Ho JT; Tan PH
    Histopathology; 2009 Nov; 55(5):609-17. PubMed ID: 19912367
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP; Cohen C; Hanley KZ; Li XB
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation.
    Sanders ME; Podoll MB
    Surg Pathol Clin; 2022 Mar; 15(1):95-103. PubMed ID: 35236636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.